Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 9:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1465–1488 of 2,476 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Tissue Control Group Clear all

Conditions: Exercise, Healthy
Interventions: Osteogenic Index Optimized Exercise Training Program; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 40 Years
Enrollment: 206 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Lawrence, Kansas • Pittsburgh, Pennsylvania

Conditions: Severe Sepsis, Septic Shock
Interventions: Pioglitazone hydrochloride; Drug
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: Not listed
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Plasmodium Falciparum Infection
Interventions: Chloroquine, PfSPZ (NF54) Challenge, Placebo; Drug · Biological · Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Small Cell Lung Carcinoma
Interventions: JDQ443; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Orlando, Florida • San Antonio, Texas

Conditions: Abscess of Skin and/or Subcutaneous Tissue
Interventions: Traditional Incision and Drainage., Loop drainage; Procedure
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Diabetic Foot Ulcer
Interventions: Lavior Diabetic Wound Gel, Smith & Nephew Solosite Gel Hydrogel Wound Dressing; Drug
Lead sponsor: Lavior Pharma Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Stroke
Interventions: hyaluronidase plus saline, saline; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Ambulation Difficulty, Gait, Unsteady, Fall, Position Sense Disorders
Interventions: Optical flow perturbations, Normal walking; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 65 Years and older
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Multiple Sclerosis
Interventions: Lido Workset; Device
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2012
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Spastic Cerebral Palsy
Interventions: Extended-release Epidural morphine (EREM) 80, Extended-release Epidural Morphine (EREM) 120, Control: Saline; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 2 Years to 12 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Retinitis Pigmentosa, Retinal Dystrophy
Interventions: Observational; Other
Lead sponsor: Nanoscope Therapeutics Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 7
States / cities: Phoenix, Arizona • Beverly Hills, California • Miami, Florida + 4 more

Conditions: Sleeve Gastrectomy
Interventions: Alcohol (Ethanol); Drug
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 21 Years to 64 Years
Enrollment: 88 participants
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Temporomandibular Disorders (TMD)
Interventions: Standard care, Physical Therapy (PT); Other
Lead sponsor: Brooke Army Medical Center; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Fort Sam Houston, Texas

Conditions: Opioid-induced Constipation
Interventions: Methylnaltrexone Bromide, Placebo-Normal Saline; Drug
Lead sponsor: St. John Health System, Michigan; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Southfield, Michigan

Conditions: General Medicine, Emergency Medicine, Mobile Health
Interventions: Epharmix/CareSignal eHealth; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 5 Years and older
Enrollment: 327 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Liver Damage
Interventions: The Medtronic Portable Bypass System (PBS®); Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteoarthritis, Knee
Interventions: Genicular nerve radiofrequency ablation, Pain Management Radiofrequency Kit; Procedure · Device
Lead sponsor: Millennium Pain Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 3
States / cities: Bloomington, Illinois • Decatur, Illinois • Peoria, Illinois

Conditions: Schizophrenia, Parkinson's Disease
Interventions: O-15 Water, 18F-Fluoro-L-dopa; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 90 Years
Enrollment: 502 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2002
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Muscle Atrophy
Interventions: Massage; Other
Lead sponsor: Esther Dupont-Versteegden; Other
Eligibility: 18 Years to 30 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Long QT Syndrome
Interventions: Eleclazine; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 5
States / cities: DeLand, Florida • Miami, Florida • Orlando, Florida + 2 more

Conditions: Scar, Hypertrophic Scar, Mammary Disorder
Interventions: Botulinum Toxins, Normal saline; Drug · Other
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Celiac Disease
Interventions: Gluten containing snack bar; Dietary Supplement
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 75 Years
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 3
States / cities: Pasadena, California • Chicago, Illinois • Rochester, Minnesota

Conditions: Type 1 Diabetes
Interventions: MPC closed-loop system, t:slim X2 pump with Dexcom G6 CGM and Control IQ; Device
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 2
States / cities: Portland, Oregon • Seattle, Washington

Conditions: NF1, Congenital Pseudarthrosis of Tibia
Interventions: INFUSE Bone Graft (BMP-2), Control Group; Device · Procedure
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 2 Years to 18 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 15
States / cities: Birmingham, Alabama • Los Angeles, California • Washington D.C., District of Columbia + 10 more

Search by objective public record fields.

Bone and Body Composition Adaptations to Physical Training

Pharmacokinetic and Biomarker Study of Pioglitazone in Adolescents With Severe Sepsis and Septic Shock

PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United States

A Phase 1 Study to Evaluate the Pharmacokinetics of JDQ443 in Participants With Hepatic Impairment Compared to Matched Healthy Control Participants.

Loop Drainage: Effectiveness in Treating Cutaneous Abscesses

Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds

Myofascial Dysfunction in Post Stroke Shoulder Pain

The Sensorimotor Locus of Balance Control in Elderly Gait

Lido Workset Study

Extended-release Epidural Morphine for Acute Post-operative Analgesia Following Selective Dorsal Rhizotomy in Children

Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDT

Alcohol After Bariatric Surgery 2

The Effect of Manual Physical Therapy and Exercise in Addition to Routine Dental Care in Individuals With Temporomandibular Disorders

Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit

Improving Follow-Up for Discharged Emergency Care Patients

Hypothermic Machine Preservation-Phase 2

Efficacy of Cooled and Monopolar Radiofrequency Ablation of the Geniculate Nerves for the Treatment of Chronic Osteoarthritic Knee Pain

PET Scanning in Parkinson s Disease

Mechanisms Underlying Local and Systemic Effects of Massage

Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function

The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar Formation

Tissue Destruction and Healing in Celiac Disease

Two Way Crossover Closed Loop MPC vs Control IQ

A Study of INFUSE Bone Graft (BMP-2) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF1)